Advertisement
Screener

NEUROCRINE BIOSCIENCES INC (NBIX) Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property

3.4 / 5 stars · 72/105 Roast Me

NEUROCRINE BIOSCIENCES INC Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property

NEUROCRINE BIOSCIENCES INC (NBIX) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-07-29.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnDispositionOfAssets · last filed 2015-07-29

  • NEUROCRINE BIOSCIENCES INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2015-06-30 was $0.00, a 100.00% decline year-over-year.
  • NEUROCRINE BIOSCIENCES INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2015-03-31 was $9.00K.
  • NEUROCRINE BIOSCIENCES INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2014-12-31 was $0.00.
  • NEUROCRINE BIOSCIENCES INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2014-09-30 was $1.00K, a 83.33% decline year-over-year.
  • NEUROCRINE BIOSCIENCES INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2014 was -$4.00K, a 110.81% decline from fiscal 2013.
  • NEUROCRINE BIOSCIENCES INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2013 was $37.00K, a 15.63% increase from fiscal 2012.
  • NEUROCRINE BIOSCIENCES INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2012 was $32.00K, a 86.78% decline from fiscal 2011.
  • NEUROCRINE BIOSCIENCES INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2011 was $242.00K, a 17.69% decline from fiscal 2010.
Period endGain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 monthGain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 monthGain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 monthGain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month
2015-06-30$0.00
10-Q · filed 2015-07-29
$9.00K
10-Q · filed 2015-07-29
$9.00K
derived: sum of 3 quarters · filed 2015-07-29
$10.00K
derived: sum of 4 quarters · filed 2015-07-29
2015-03-31$9.00K
10-Q · filed 2015-04-30
$9.00K
derived: sum of 2 quarters · filed 2015-04-30
$10.00K
derived: sum of 3 quarters · filed 2015-04-30
$15.00K
derived: sum of 4 quarters · filed 2015-07-29
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09
$1.00K
derived: sum of 2 quarters · filed 2015-02-09
$6.00K
derived: sum of 3 quarters · filed 2015-07-29
-$4.00K
10-K · filed 2015-02-09
2014-09-30$1.00K
10-Q · filed 2014-11-04
$6.00K
derived: sum of 2 quarters · filed 2015-07-29
-$4.00K
10-Q · filed 2014-11-04
-$5.00K
derived: sum of 4 quarters · filed 2015-07-29
2014-06-30$5.00K
10-Q · filed 2015-07-29
-$5.00K
10-Q · filed 2015-07-29
-$6.00K
derived: sum of 3 quarters · filed 2015-07-29
$0.00
derived: sum of 4 quarters · filed 2015-07-29
2014-03-31-$10.00K
10-Q · filed 2015-04-30
-$11.00K
derived: sum of 2 quarters · filed 2015-04-30
-$5.00K
derived: sum of 3 quarters · filed 2015-04-30
$14.00K
derived: sum of 4 quarters · filed 2015-04-30
2013-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09
$5.00K
derived: sum of 2 quarters · filed 2015-02-09
$24.00K
derived: sum of 3 quarters · filed 2015-02-09
$37.00K
10-K · filed 2015-02-09
2013-09-30$6.00K
10-Q · filed 2014-11-04
$25.00K
derived: sum of 2 quarters · filed 2014-11-04
$38.00K
10-Q · filed 2014-11-04
$45.00K
derived: sum of 4 quarters · filed 2015-02-09
2013-06-30$19.00K
10-Q · filed 2014-08-06
$32.00K
10-Q · filed 2014-08-06
$39.00K
derived: sum of 3 quarters · filed 2015-02-09
$39.00K
derived: sum of 4 quarters · filed 2015-02-09
2013-03-31$13.00K
10-Q · filed 2014-05-01
$20.00K
derived: sum of 2 quarters · filed 2015-02-09
$20.00K
derived: sum of 3 quarters · filed 2015-02-09
$20.00K
derived: sum of 4 quarters · filed 2015-02-09
2012-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-09
$7.00K
derived: sum of 2 quarters · filed 2015-02-09
$7.00K
derived: sum of 3 quarters · filed 2015-02-09
$32.00K
10-K · filed 2015-02-09
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29
$0.00
derived: sum of 2 quarters · filed 2013-10-29
$25.00K
10-Q · filed 2013-10-29
$83.00K
derived: sum of 4 quarters · filed 2014-02-11
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26
$25.00K
10-Q · filed 2013-07-26
$83.00K
derived: sum of 3 quarters · filed 2014-02-11
$169.00K
derived: sum of 4 quarters · filed 2014-02-11
2012-03-31$25.00K
10-Q · filed 2013-05-02
$83.00K
derived: sum of 2 quarters · filed 2014-02-11
$169.00K
derived: sum of 3 quarters · filed 2014-02-11
$187.00K
derived: sum of 4 quarters · filed 2014-02-11
2011-12-31$58.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11
$144.00K
derived: sum of 2 quarters · filed 2014-02-11
$162.00K
derived: sum of 3 quarters · filed 2014-02-11
$242.00K
10-K · filed 2014-02-11
2011-09-30$86.00K
10-Q · filed 2012-10-31
$104.00K
derived: sum of 2 quarters · filed 2012-10-31
$184.00K
10-Q · filed 2012-10-31
$276.00K
derived: sum of 4 quarters · filed 2013-02-08
2011-06-30$18.00K
10-Q · filed 2012-07-31
$98.00K
10-Q · filed 2012-07-31
$190.00K
derived: sum of 3 quarters · filed 2013-02-08
$224.00K
derived: sum of 4 quarters · filed 2013-02-08
2011-03-31$80.00K
10-Q · filed 2012-05-02
$172.00K
derived: sum of 2 quarters · filed 2013-02-08
$206.00K
derived: sum of 3 quarters · filed 2013-02-08
$259.00K
derived: sum of 4 quarters · filed 2013-02-08
2010-12-31$92.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-08
$126.00K
derived: sum of 2 quarters · filed 2013-02-08
$179.00K
derived: sum of 3 quarters · filed 2013-02-08
$294.00K
10-K · filed 2013-02-08
2010-09-30$34.00K
10-Q · filed 2011-10-31
$87.00K
derived: sum of 2 quarters · filed 2011-10-31
$202.00K
10-Q · filed 2011-10-31
2010-06-30$53.00K
10-Q · filed 2011-07-29
$168.00K
10-Q · filed 2011-07-29
2009-12-31$841.00K
10-K · filed 2012-02-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXELIXIS, INC. (EXEL)United States$14.358B16.15
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78